Can blood metabolomics predict the course of MS?
- Lead researcher:
- Professor Daniel Anthony
- Based at:
- University of Oxford
- MS Society funding:
Right now we don't have any tests that can predict if someone will go on to develop MS after experiencing their first symptoms.
We also can't predict when someone will go from have relapsing to progressive MS. This can delay diagnosis and make it hard to find effective treatments that can halt progression.
What happens in this project?
Our researchers are working to develop a blood test that can tell the difference between relapsing and progressive MS. It works by measuring a number of molecules in the blood that are found in different amounts in people with and without MS.
The test could also help to monitor how someone's MS progresses over time and quickly discover if a treatment is going to be effective or not.
How will it help people with MS?
For people living with MS, knowing what stage their condition is at is essential to understanding their prognosis and treatment options. This research could help reduce uncertainty for people around the type of MS they have and how it is progressing.
The difference you can make
MS is unpredictable and can be hard to live with. Giving people greater certainty about how their condition will progress is one of our top seven organisational goals. But we can only do this with your support.